Bilateral Facial Palsy following Ipilimumab Infusion for Melanoma

Otolaryngology - Head and Neck Surgery (United States)

Volumn 153, Issue 5, 2015, Pages 894-895

  Altman, Ashley L ^a   Golub, Justin S ^a,b   Pensak, Myles L ^a   Samy, Ravi N ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

facial palsy; ipilimumab; neuropathy

Indexed keywords

IPILIMUMAB; PREDNISONE; MONOCLONAL ANTIBODY;

ADULT; AUDIOMETRY; CANCER CHEMOTHERAPY; CASE REPORT; CORTICOSTEROID THERAPY; DRUG DOSE INCREASE; FACIAL NERVE PARALYSIS; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MALE; MELANOMA METASTASIS; METASTATIC MELANOMA; PAROTID GLAND CANCER; PAROTIDECTOMY; SHORT SURVEY; TELEPHONE INTERVIEW; CHEMICALLY INDUCED; FACIAL PARALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; PAROTID NEOPLASMS; PATHOLOGY; SECONDARY; SKIN NEOPLASMS;

ADULT; ANTIBODIES, MONOCLONAL; FACIAL PARALYSIS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MELANOMA; PAROTID NEOPLASMS; SKIN NEOPLASMS;

EID: 84946051731     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599815606701     Document Type: Short Survey

References (5)

1. Culos KA, Cuellar S,. Novel targets in the treatment of advanced melanoma: new first-line treatment options. Ann Pharamcother. 2013; 47: 519-526.
2. O'Day SJ, Maio M, Chiarion-Sileni V, et al. Efficacy and safety of ipilimumab monotherapy in patients with pre-treated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol. 2010; 21: 1712-1717.
3. DiGiacomo AM, Biagioli M, Maio M,. The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications. Semin Oncol. 2010; 37: 499-507.
4. Jinnur P, Lim KG,. Severe acute orthopnea: ipilimumab-induced bilateral phrenic nerve neuropathy [published online May 9, 2015]. Lung.
5. Manousakis G, Koch J, Sommerville RB, et al. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve. 2013; 48: 440-444.